跳至主要内容
临床试验/TCTR20190330002
TCTR20190330002已完成不适用

Effects of exercise intervention on cardiac function and exercise capacity in breast cancer patient receiving anthracycline chemotherapy.

6F, No.35, Siao-Dong Road, Tainan, 704, Taiwan, R.O.C0 个研究点目标入组 30 人开始时间: 2019年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

This study revealed that moderate-to-high intensity exercise training in breast cancer patients undergoing chemotherapy prevents impairment of cardiac function and improves exercise capacity.

研究设计

研究类型
Interventional

入排标准

年龄范围
30 Years 至 65 Years(—)
性别
Female

入选标准

  • (1)30-65 years old diagnosed with primary breast cancer, (2)breast cancer stage I-III without receiving radiotherapy and target therapy, (3)scheduled for chemotherapy with anthracycline (e.g.doxorubicin, epirubicin), (4)able to follow exercise protocol

排除标准

  • (1) acute infectious disease, (2) severe neurological, respiratory and renal deficiencies, (3) severe cardiac or cardiovascular disease (e.g. LVEF<50%), (4) other concurrent malignant disease, (5) life expectancy<6 months, (6) enrolled in studies involving exercise training, (7) unable to walk or stand, (8) ongoing pharmacological cardio-protection

研究者

发起方
6F, No.35, Siao-Dong Road, Tainan, 704, Taiwan, R.O.C

相似试验

The exercise effects on cardiotoxicity in breast... | 临床试验